INCREASED INCIDENCE OF IMPAIRED FASTING GLUCOSE (IFG) AMONG HYPERTENSIVE PATIENTS NAÏVE TO HYPOLIPIDEMIC TREATMENT
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Hypertension"
DOI: 10.1097/01.hjh.0000837348.04843.5b
Abstract: Objective: Impaired fasting glucose (IFG) predisposes to future development of type 2 diabetes mellitus (T2DM) and may also be associated with increased cardiovascular disease (CVD) risk. Hypertension is an established CVD risk factor. The aim… read more here.
Keywords: ifg; fasting glucose; impaired fasting; hypertensive patients ... See more keywords
Cardiac Alarmins as Residual Risk Markers of Atherosclerosis under Hypolipidemic Therapy
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms231911174
Abstract: Increased levels of low-density lipoproteins are the main risk factor in the initiation and progression of atherosclerosis. Although statin treatment can effectively lower these levels, there is still a residual risk of cardiovascular events. We… read more here.
Keywords: group; risk; cardiac alarmins; residual risk ... See more keywords